Naphazoline Hydrochloride CAS: 550-99-2

CAS NO: 550-99-2
Naphazoline Hydrochloride
Chemical Name: Naphazoline hydrochloride
Molecular Formula: C14H15ClN2
Formula Weight: 246.74
CAS No.: 550-99-2
Description Review
Description

Naphazoline Hydrochloride (CAS: 550-99-2) is a medication that belongs to the class of drugs known as sympathomimetic agents. It is used primarily as a nasal decongestant to relieve the symptoms of nasal congestion and related conditions such as hay fever, sinusitis, and the common cold.

Chemical name:

Naphazoline Hydrochloride has a chemical name of 2-(1-naphthylmethyl)-2-imidazoline hydrochloride.

Molecular formula:

The molecular formula for Naphazoline Hydrochloride is C14H15N3.HCl.

Formula weight:

The formula weight of Naphazoline Hydrochloride is 263.75 g/mol.

CAS No:

The CAS number for Naphazoline Hydrochloride is 550-99-2.

Top ten keywords from Google:

  1. Nasal decongestant
  2. Hay fever
  3. Sinusitis
  4. Common cold
  5. Sympathomimetic agent
  6. Topical vasoconstrictor
  7. Ophthalmic solution
  8. Eye irritation
  9. Allergic conjunctivitis
  10. Side effects

Synonyms:

Some synonyms for Naphazoline Hydrochloride include Privine, Albalon, VasoClear, Clear Eyes, and others.

Health benefits of this product:

Naphazoline Hydrochloride is primarily used as a nasal decongestant, which helps reduce swelling in the nasal passages and open them up to facilitate breathing. The medication is also used to treat eye irritation caused by allergies, allergic conjunctivitis, or other irritants.

Potential effects:

Naphazoline Hydrochloride is a topical vasoconstrictor, meaning it constricts blood vessels in the affected area. This constriction reduces swelling, redness, and inflammation, making breathing easier and relieving eye irritation. The medication can begin to work within minutes of being applied and can last for several hours.

Product mechanism:

Naphazoline Hydrochloride works by stimulating the alpha-adrenergic receptors found in the nasal mucosa and ocular tissues. This stimulation causes the blood vessels in these areas to constrict, reducing inflammation and opening up the airways.

Safety:

When used as directed, Naphazoline Hydrochloride is generally considered safe. However, like any medication, it can cause side effects and should not be used by everyone. People who have high blood pressure or heart disease should avoid using Naphazoline Hydrochloride without first consulting their doctor. Pregnant women and those who are breastfeeding should also consult with their doctor before using this medication.

Side effects:

Common side effects of Naphazoline Hydrochloride include temporary burning, stinging, or dryness in the nose or eyes. In some cases, the medication can cause increased blood pressure, headache, nausea, nervousness, or insomnia. Serious side effects such as irregular heartbeat or difficulty breathing are rare but can occur in some people.

Dosing information:

Naphazoline Hydrochloride is available in various forms, including nasal sprays, drops, and ophthalmic solutions. The dosing instructions for each form may vary, so it's important to read the package insert carefully and follow the directions provided by your healthcare provider. It's also essential to use the medication only as directed and to avoid using it for longer than recommended.

Conclusion:

Naphazoline Hydrochloride is an effective medication for relieving nasal congestion and eye irritation caused by allergies, irritants, or other factors. When used correctly, it can provide fast relief from symptoms and improve breathing and overall comfort. However, like any medication, it can cause side effects and should be used with caution, particularly by those with underlying health conditions. If you have questions or concerns about using Naphazoline Hydrochloride, talk to your healthcare provider.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code